Laboratorio Elea Phoenix

Executive Summary

Laboratorio Elea Phoenix is a well-established Argentine pharmaceutical company with over 80 years of history, specializing in branded generic drugs across various therapeutic areas including cardiovascular, central nervous system, and oncology. With a workforce of 200-500 employees and a commercial-stage operation, the company has built a strong domestic presence and is gradually expanding into international markets. Its strategy focuses on developing high-quality, affordable generics that meet local and regional regulatory standards. Elea Phoenix benefits from Argentina's growing pharmaceutical market and its own vertically integrated manufacturing capabilities, which enable cost-effective production and supply chain control. The company's private ownership allows for long-term strategic planning without quarterly earnings pressure, positioning it for steady growth in Latin America.

Upcoming Catalysts (preview)

• Q1 2027Launch of a new generic oncology drug in Argentina75% success
• Q4 2026Receipt of ANMAT approval for a novel branded generic80% success
• Q2 2027Partnership with a multinational for distribution in Brazil60% success